Association of Serum Ferritin Levels with Liver Fibrosis Severity in Patients with Non-Alcoholic Fatty Liver Disease

Authors

  • Dr. Jairaj V Bomman , Dr. Aishhwarrya Umeshchandara G, Dr. Karthik Ravindra Dhaded

Keywords:

Non-alcoholic fatty liver disease, Serum ferritin, Liver fibrosis, FibroScan, FIB-4, NAFLD Fibrosis Score, Non-invasive biomarkers.

Abstract

Background: Non-alcoholic fatty liverdisease (NAFLD) is the most prevalentchronic liver disease worldwide andencompasses a spectrum ranging from simple hepatic steatosis to non-alcoholicsteatohepatitis, progressive fibrosis,cirrhosis, and hepatocellular carcinoma

References

1. Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, Kleiner DE, Loomba R. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 1;77(5):1797-1835. 2023 10.1097/HEP.0000000000000323. May doi: Epub 2023 Mar 17. PMID: 36727674; PMCID: PMC10735173.

Downloads

Published

2026-06-15

How to Cite

Dr. Jairaj V Bomman , Dr. Aishhwarrya Umeshchandara G, Dr. Karthik Ravindra Dhaded. (2026). Association of Serum Ferritin Levels with Liver Fibrosis Severity in Patients with Non-Alcoholic Fatty Liver Disease . International Journal of Pharmacy Research & Technology (IJPRT), 16(1), 4639–4646. Retrieved from https://ijprt.org/index.php/pub/article/view/2313

Issue

Section

Research Article